1. Home
  2. IMAB vs STIM Comparison

IMAB vs STIM Comparison

Compare IMAB & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • STIM
  • Stock Information
  • Founded
  • IMAB 2014
  • STIM 2003
  • Country
  • IMAB United States
  • STIM United States
  • Employees
  • IMAB N/A
  • STIM N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • STIM Medical/Dental Instruments
  • Sector
  • IMAB Health Care
  • STIM Health Care
  • Exchange
  • IMAB Nasdaq
  • STIM Nasdaq
  • Market Cap
  • IMAB 79.9M
  • STIM 192.0M
  • IPO Year
  • IMAB 2020
  • STIM 2018
  • Fundamental
  • Price
  • IMAB $0.96
  • STIM $4.36
  • Analyst Decision
  • IMAB Strong Buy
  • STIM Buy
  • Analyst Count
  • IMAB 3
  • STIM 4
  • Target Price
  • IMAB $8.00
  • STIM $4.67
  • AVG Volume (30 Days)
  • IMAB 286.0K
  • STIM 1.7M
  • Earning Date
  • IMAB 03-13-2025
  • STIM 03-04-2025
  • Dividend Yield
  • IMAB N/A
  • STIM N/A
  • EPS Growth
  • IMAB N/A
  • STIM N/A
  • EPS
  • IMAB N/A
  • STIM N/A
  • Revenue
  • IMAB $569,464.00
  • STIM $72,711,000.00
  • Revenue This Year
  • IMAB N/A
  • STIM $3.23
  • Revenue Next Year
  • IMAB N/A
  • STIM $29.55
  • P/E Ratio
  • IMAB N/A
  • STIM N/A
  • Revenue Growth
  • IMAB N/A
  • STIM 5.03
  • 52 Week Low
  • IMAB $0.84
  • STIM $0.52
  • 52 Week High
  • IMAB $2.00
  • STIM $5.07
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 45.33
  • STIM 73.44
  • Support Level
  • IMAB $0.95
  • STIM $2.80
  • Resistance Level
  • IMAB $1.04
  • STIM $3.65
  • Average True Range (ATR)
  • IMAB 0.06
  • STIM 0.47
  • MACD
  • IMAB -0.01
  • STIM 0.06
  • Stochastic Oscillator
  • IMAB 19.88
  • STIM 89.01

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: